KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Asset Utilization Ratio (2016 - 2025)

Arbutus Biopharma (ABUS) has disclosed Asset Utilization Ratio for 12 consecutive years, with 0.15 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 222.93% to 0.15 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.15 through Dec 2025, up 222.93% year-over-year, with the annual reading at 0.12 for FY2025, 178.41% up from the prior year.
  • Asset Utilization Ratio hit 0.15 in Q4 2025 for Arbutus Biopharma, up from 0.15 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.2 in Q4 2022 to a low of 0.04 in Q3 2024.
  • Historically, Asset Utilization Ratio has averaged 0.11 across 5 years, with a median of 0.11 in 2023.
  • Biggest five-year swings in Asset Utilization Ratio: soared 229.19% in 2022 and later tumbled 66.16% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.06 in 2021, then skyrocketed by 229.19% to 0.2 in 2022, then crashed by 38.75% to 0.12 in 2023, then plummeted by 62.12% to 0.05 in 2024, then soared by 222.93% to 0.15 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ABUS at 0.15 in Q4 2025, 0.15 in Q3 2025, and 0.14 in Q2 2025.